IndiaTickerLatest filing: Ipca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Financial Results For 1St Quarter Ended 30Th June, 2026
ObservedCompany dossier
IPCA Laboratories
NSE:IPCALAB · ISIN INE571A01038
- Close
- ₹1,774.5 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
IPCA Laboratories
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹2,245.4 Cr · PAT ₹276.4 Cr.
Exchange XBRLLatest ownership: promoter group 44.72% and public 55.28% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing Ipca Laboratories Ltd - 524494 - Board Meeting Intimation for Standalone And Consolidated Financial Results For 1St Quarter Ended 30Th June, 2026
BSE · financial results
Observed
Source filing Ipca Laboratories Ltd - 524494 - Intimation Of Web Link To Non-Email Cases
BSE · exchange filing
Observed
Archived filing Updates - IPCA Laboratories Limited
NSE · annual report
Observed
Source filing Ipca Laboratories Ltd - 524494 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹2,245.4 Cr
- Profit after tax
- ₹276.4 Cr
- EPS
- ₹9.78
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 44.72%
- Public
- 55.28%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL